| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marta Pertichetti, Simona Serioli, Francesco Belotti, Davide Mattavelli, Alberto Schreiber, Carlo Cappelli, Alessandro Padovani, Roberto Gasparotti, Piero Nicolai, Marco M Fontanella, Francesco Dogliett. Pituitary adenomas and neuropsychological status: a systematic literature review. Neurosurgical review. vol 43. issue 4. 2020-11-26. PMID:31250149. |
postoperative improvement of qol, somatic symptoms, obsessive-compulsive disorder, and coping strategies was seen in cd and acromegaly. |
2020-11-26 |
2023-08-13 |
Not clear |
| Adesh Shrivastava, Nasser Mohammed, Zhiyuan Xu, Roman Liščák, Mikulas Kosak, Michal Krsek, Khaled Abdel Karim, Cheng-Chia Lee, Nuria Martínez-Moreno, Mary Lee Vance, L Dade Lunsford, Jason P Sheeha. Outcomes After Gamma Knife Stereotactic Radiosurgery in Pediatric Patients with Cushing Disease or Acromegaly: A Multi-Institutional Study. World neurosurgery. vol 125. 2020-01-03. PMID:30790739. |
this study examines the role of stereotactic radiosurgery in the management of pediatric acromegaly or patients with cushing disease (cd). |
2020-01-03 |
2023-08-13 |
Not clear |
| Fabienne Langlois, Shirley McCartney, Maria Fleseri. Recent Progress in the Medical Therapy of Pituitary Tumors. Endocrinology and metabolism (Seoul, Korea). vol 32. issue 2. 2019-11-20. PMID:28685507. |
however, medical/pharmacological therapy plays an important role in controlling hormone-producing pituitary adenomas, especially for patients with acromegaly and cushing disease (cd). |
2019-11-20 |
2023-08-13 |
Not clear |
| Fabienne Langlois, Shirley McCartney, Maria Fleseri. Recent Progress in the Medical Therapy of Pituitary Tumors. Endocrinology and metabolism (Seoul, Korea). vol 32. issue 2. 2019-11-20. PMID:28685507. |
in this review, the medical armamentarium for treating cd, acromegaly, prolactinomas, nfa, and carcinomas/aggressive atypical adenomas will be presented. |
2019-11-20 |
2023-08-13 |
Not clear |
| Amitabh Gupta, Zhiyuan Xu, Hideyuki Kano, Nathaniel Sisterson, Yan-Hua Su, Michal Krsek, Ahmed M Nabeel, Amr El-Shehaby, Khaled A Karim, Nuria Martínez-Moreno, David Mathieu, Brendan J McShane, Roberto Martínez-Álvarez, Wael A Reda, Roman Liscak, Cheng-Chia Lee, L Dade Lunsford, Jason P Sheeha. Upfront Gamma Knife radiosurgery for Cushing's disease and acromegaly: a multicenter, international study. Journal of neurosurgery. vol 131. issue 2. 2019-11-20. PMID:30117768. |
gamma knife radiosurgery (gks) is typically used after failed resection in patients with cushing's disease (cd) and acromegaly. |
2019-11-20 |
2023-08-13 |
Not clear |
| Amitabh Gupta, Zhiyuan Xu, Hideyuki Kano, Nathaniel Sisterson, Yan-Hua Su, Michal Krsek, Ahmed M Nabeel, Amr El-Shehaby, Khaled A Karim, Nuria Martínez-Moreno, David Mathieu, Brendan J McShane, Roberto Martínez-Álvarez, Wael A Reda, Roman Liscak, Cheng-Chia Lee, L Dade Lunsford, Jason P Sheeha. Upfront Gamma Knife radiosurgery for Cushing's disease and acromegaly: a multicenter, international study. Journal of neurosurgery. vol 131. issue 2. 2019-11-20. PMID:30117768. |
little is known about the upfront role of gks for patients with cd and acromegaly. |
2019-11-20 |
2023-08-13 |
Not clear |
| Federico Gatto, Marica Arvigo, Jessica Amarù, Claudia Campana, Francesco Cocchiara, Giulia Graziani, Eleonora Bruzzone, Massimo Giusti, Mara Boschetti, Diego Feron. Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells. Pituitary. vol 22. issue 1. 2019-03-04. PMID:30483918. |
pasireotide is a second-generation somatostatin (srif) receptor ligand (srl), approved for medical treatment of acromegaly and cushing's disease (cd). |
2019-03-04 |
2023-08-13 |
Not clear |
| Sema Ciftci Dogansen, Gulsah Yenidunya Yalin, Seher Tanrikulu, Sakin Tekin, Nihan Nizam, Bilge Bilgic, Serra Sencer, Sema Yarma. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas. Pituitary. vol 21. issue 4. 2018-10-16. PMID:29460202. |
to assess baseline t2-weighted signal intensity (t2-wsi) of functional pituitary adenomas (fpa), and to investigate the relationship of baseline t2-wsi with clinical features, histopathological granulation patterns, and response to treatment in patients with acromegaly, prolactinoma and cushing's disease (cd). |
2018-10-16 |
2023-08-13 |
Not clear |
| Julie M Silverstei. Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly. Pituitary. vol 19. issue 5. 2017-04-04. PMID:27405306. |
cushing's disease (cd) and acromegaly are characterized by excessive hormone secretion resulting in comorbidities such as impaired glucose metabolism, diabetes and hypertension. |
2017-04-04 |
2023-08-13 |
Not clear |
| Julie M Silverstei. Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly. Pituitary. vol 19. issue 5. 2017-04-04. PMID:27405306. |
pasireotide is a new-generation, multireceptor-targeted somatostatin receptor ligand approved for cd (subcutaneous [sc] injection formulation) and acromegaly (long-acting release [lar] formulation). |
2017-04-04 |
2023-08-13 |
Not clear |
| N C van Varsseveld, C C van Bunderen, A A M Franken, H P F Koppeschaar, A J van der Lely, M L Dren. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults. Pituitary. vol 19. issue 4. 2017-03-22. PMID:27048484. |
the aim of this study was to investigate characteristics and fracture occurrence at start of (baseline) and during long-term gh replacement therapy in ghd adults previously treated for cushing's disease (cd) or acromegaly, compared to patients with previous nonfunctioning pituitary adenoma (nfpa). |
2017-03-22 |
2023-08-13 |
Not clear |
| Or Cohen-Inbar, Arjun Ramesh, Zhiyuan Xu, Mary Lee Vance, David Schlesinger, Jason P Sheeha. Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long-term risk of hypopituitarism. Clinical endocrinology. vol 84. issue 4. 2016-12-13. PMID:26341248. |
for patient with a recurrent or residual acromegaly or cushing's disease (cd) after resection, gamma knife radiosurgery (gkrs) is often used. |
2016-12-13 |
2023-08-13 |
Not clear |
| Or Cohen-Inbar, Arjun Ramesh, Zhiyuan Xu, Mary Lee Vance, David Schlesinger, Jason P Sheeha. Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long-term risk of hypopituitarism. Clinical endocrinology. vol 84. issue 4. 2016-12-13. PMID:26341248. |
the paucity of studies with long-term follow-up has hampered understanding of the latent risks of hypopituitarism in patients with acromegaly or cd. |
2016-12-13 |
2023-08-13 |
Not clear |
| Or Cohen-Inbar, Arjun Ramesh, Zhiyuan Xu, Mary Lee Vance, David Schlesinger, Jason P Sheeha. Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long-term risk of hypopituitarism. Clinical endocrinology. vol 84. issue 4. 2016-12-13. PMID:26341248. |
we report the long-term risks of hypopituitarism for patients treated with gkrs for acromegaly or cd. |
2016-12-13 |
2023-08-13 |
Not clear |
| T Psaras, M Milian, V Hattermann, B E Will, M Tatagiba, J Honegge. Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly. Journal of endocrinological investigation. vol 34. issue 7. 2012-03-26. PMID:21060251. |
cushing's disease (cd) and acromegaly (ac) are associated with impairment in quality of life (qol) and neurocognition that can persist after successful treatment. |
2012-03-26 |
2023-08-12 |
Not clear |
| T Psaras, M Milian, V Hattermann, T Freiman, B Gallwitz, J Honegge. Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. vol 119. issue 1. 2011-05-25. PMID:20827660. |
the aim of the study was to analyze the time-to-diagnosis interval in patients with cushing's disease (cd) and acromegaly (ac), to assess factors that promote early disease detection and to investigate the medical fields diagnosing the pathologies. |
2011-05-25 |
2023-08-12 |
Not clear |
| Tsambika Psaras, Monika Milian, Valerie Hattermann, Baptist Gallwitz, Thomas Freiman, Juergen Honegge. Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement? Acta neurochirurgica. vol 152. issue 2. 2010-06-07. PMID:19911113. |
evaluation of aftercare, medical therapy and remission rate for cushing's disease (cd) and acromegaly (ac). |
2010-06-07 |
2023-08-12 |
Not clear |
| Takanori Ebisawa, Katsuyoshi Tojo, Naoko Tajima, Masami Kamio, Yutaka Oki, Katsuhiko Ono, Hironobu Sasan. Immunohistochemical analysis of 11-beta-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical Cushing's disease due to pituitary macroadenoma. Endocrine pathology. vol 19. issue 4. 2009-02-24. PMID:19048413. |
in this study, immunohistochemical analysis of the resected tumors were performed to evaluate the expression of 11beta-hydroxysteroid dehydrogenase type 2 (11betahsd2) and glucocorticoid receptor (gr) in pituitary tissues obtained from two scd (macroadenomas), eight cushing's disease (cd) (microadenomas), nine acromegaly, and nine normal pituitary (np). |
2009-02-24 |
2023-08-12 |
Not clear |
| F R Pimentel-Filho, M E R Silva, K C Nogueira, K Berger, A Cukiert, B Liberma. Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively. Journal of endocrinological investigation. vol 28. issue 6. 2005-09-29. PMID:16117190. |
blood samples for acth and cortisol determination were obtained immediately before, at the end of surgery and at 4, 8, 12, 16, 24, 48 and 72 h after surgery, in 8 cured cd patients (group i), 9 not cured cd patients (group ii) and in 7 subjects with acromegaly (group iii) who presented normal hpa axis (control group). |
2005-09-29 |
2023-08-12 |
human |
| B Ferramosca, D Bianchi, D Serra, R Savini, A S Villecco, R Bugiardin. [Cardiological findings in acromegaly]. Minerva medica. vol 78. issue 24. 1988-03-15. PMID:3431727. |
in order to assess the existence and course of subclinical cardiac alterations, 8 acromegaly patients were examined: 4 males and 4 females aged 31-56 with gh levels of 24-70 ng/ml (m + cd x 47 +/- 16) and no cardiovascular symptoms. |
1988-03-15 |
2023-08-11 |
Not clear |